COPPELL, Texas--(BUSINESS WIRE)--Nov. 10, 2015--
Mannatech,
Incorporated (NASDAQ: MTEX),
the pioneer of nutritional glycobiology, leading innovator of
naturally-sourced supplements based on Real Food Technology® solutions,
and creator of the M5MSM (Mission 5 MillionSM)
social entrepreneurial movement, today announced financial results for
its third quarter 2015.
Third quarter net sales for 2015 were $43.9 million, a decrease of 21.2%
as compared to $55.6 million in the third quarter of 2014. The net sales
comparison for the quarter was affected by the launch of the Uth
skin care product in our international markets in 2014 and by foreign
exchange rates. Net sales attributable to our Uth skin care
product were $1.0 million for the three months ended September 30, 2015,
as compared to $7.2 million in the same period in 2014. Our net sales
would have been $48.2 million in Constant dollars, which is a non-GAAP
financial measure that excludes the impact of fluctuations in foreign
currency exchange rates.
Income from operations declined to $2.2 million for the third quarter,
from $8.2 million in the same period in 2014. Net income was $0.1
million, or $0.03 per diluted share, for the third quarter 2015, as
compared to $5.1 million, or $1.89 per diluted share, for the third
quarter 2014.
The approximate number of new and continuing independent associate and
member positions held by individuals in our network and associated with
purchases of our packs or products during the twelve months ended
September 30, 2015 and 2014 were approximately 221,000 and 234,000,
respectively. Recruiting decreased 18.8% in the third quarter of 2015 as
compared to the third quarter of 2014. The number of new independent
associate and member positions in our network for the third quarter of
2015 was approximately 23,600, as compared to 29,000 in 2014.
For the three months ended September 30, 2015, our operations outside of
North America accounted for approximately 59.4% of our consolidated net
sales.
For the three months ended September 30, 2015, Asia/Pacific net sales
decreased by $8.3 million, or 27.4%, to $22.0 million, as compared to
$30.3 million for the same period in 2014. Net sales comparisons for the
third quarter were affected by the launch of our Uth skin
care product in 2014 in Asia/Pacific and the impact of fluctuations in
foreign currency exchange rates. Asia/Pacific net sales attributable to
our Uth skin care product were $0.4 million for the three
months ended September 30, 2015 as compared to $6.0 million for the same
period in 2014. In Constant dollars (a non-GAAP financial measure), net
sales would have been $3.4 million higher, or $25.4 million. The
currency impact was primarily due to depreciation of the Korean Won, the
Japanese Yen and the Australian Dollar.
For the three months ended September 30, 2015, EMEA net sales decreased
by $0.8 million, or 16.3%, to $4.1 million, as compared to $4.9 million
for the same period in 2014, although in Constant dollars (a non-GAAP
financial measure), net sales for the three months ended September 30,
2015 would have been $4.9 million. The currency impact was primarily due
to the depreciation of the South African Rand and the Euro. The launch
of our Uth skin care product in 2014 in EMEA did not have a
material effect on net sales comparisons.
North American net sales decreased by $2.6 million, or 12.7%, to $17.8
million, as compared to $20.4 million for the same period in 2014 due to
a decline in associates and members that have active positions in our
network.
Our cash and cash equivalents increased by approximately $7.3 million to
a balance of $35.3 million at September 30, 2015 as compared to $28.0
million at December 31, 2014. Also, total shareholder’s equity increased
by $5.2 million to a balance of $36.6 million as compared to $31.4
million at December 31, 2014.
Non-GAAP Measures
In addition to results presented in accordance with GAAP, this press
release and related tables include certain non-GAAP financial measures,
including a presentation of constant currency measures. We disclose
operating results that have been adjusted to exclude the impact of
changes due to the translation of foreign currencies into U.S. dollars,
including changes in: Net Sales, Gross Profit, and Income from
Operations.
We believe that these non-GAAP financial measures provide useful
information to investors because they are an indicator of the strength
and performance of ongoing business operations. The constant currency
figures are financial measures used by management to provide investors
an additional perspective on trends. Although we believe the non-GAAP
financial measures enhance investors’ understanding of our business and
performance, these non-GAAP financial measures should not be considered
an exclusive alternative to accompanying GAAP financial measures.
Conference Call
Mannatech will host a conference call to discuss the quarter’s results
with investors on Wednesday, November 11, 2015 at 9 a.m. CST, 10 a.m.
EST. The live call will be webcast and can be accessed on Mannatech’s
website at http://ir.mannatech.com.
For those unable to listen to the live broadcast, a replay will be
available shortly after the call. The toll-free replay number is (855)
859-2056 (International (404) 537-3406); the Conference ID to access the
call is 65672031.
Individuals interested in Mannatech’s products or in exploring its
business opportunity can learn more at Mannatech.com.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS
|
|
(in thousands, except share amounts)
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
September 30, 2015 (unaudited)
|
|
|
December 31, 2014
|
|
Cash and cash equivalents
|
|
|
$
|
35,292
|
|
|
|
$
|
27,999
|
|
|
Restricted cash
|
|
|
|
1,512
|
|
|
|
|
1,511
|
|
|
Accounts receivable, net
|
|
|
|
272
|
|
|
|
|
504
|
|
|
Income tax receivable
|
|
|
|
20
|
|
|
|
|
4
|
|
|
Inventories, net
|
|
|
|
11,398
|
|
|
|
|
10,591
|
|
|
Prepaid expenses and other current assets
|
|
|
|
2,981
|
|
|
|
|
3,069
|
|
|
Deferred commissions
|
|
|
|
4,210
|
|
|
|
|
4,544
|
|
|
Deferred tax assets, net
|
|
|
|
1,026
|
|
|
|
|
1,141
|
|
|
Total current assets
|
|
|
|
56,711
|
|
|
|
|
49,363
|
|
|
Property and equipment, net
|
|
|
|
4,092
|
|
|
|
|
2,481
|
|
|
Construction in progress
|
|
|
|
660
|
|
|
|
|
1,622
|
|
|
Long-term restricted cash
|
|
|
|
6,459
|
|
|
|
|
7,045
|
|
|
Other assets
|
|
|
|
3,943
|
|
|
|
|
3,567
|
|
|
Long-term deferred tax assets, net
|
|
|
|
3,468
|
|
|
|
|
3,320
|
|
|
Total assets
|
|
|
$
|
75,333
|
|
|
|
$
|
67,398
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
Current portion of capital leases
|
|
|
$
|
446
|
|
|
|
$
|
901
|
|
|
Accounts payable
|
|
|
|
4,339
|
|
|
|
|
4,252
|
|
|
Accrued expenses
|
|
|
|
7,804
|
|
|
|
|
6,356
|
|
|
Commissions and incentives payable
|
|
|
|
9,840
|
|
|
|
|
7,908
|
|
|
Taxes payable
|
|
|
|
1,822
|
|
|
|
|
2,578
|
|
|
Current deferred tax liability
|
|
|
|
119
|
|
|
|
|
123
|
|
|
Deferred revenue
|
|
|
|
10,459
|
|
|
|
|
10,890
|
|
|
Total current liabilities
|
|
|
|
34,829
|
|
|
|
|
33,008
|
|
|
Capital leases, excluding current portion
|
|
|
|
699
|
|
|
|
|
852
|
|
|
Long-term deferred tax liabilities
|
|
|
|
64
|
|
|
|
|
26
|
|
|
Other long-term liabilities
|
|
|
|
3,127
|
|
|
|
|
2,136
|
|
|
Total liabilities
|
|
|
|
38,719
|
|
|
|
|
36,022
|
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity:
|
|
|
|
|
|
|
|
Preferred stock
|
|
|
|
—
|
|
|
|
|
—
|
|
|
Common stock
|
|
|
|
—
|
|
|
|
|
—
|
|
|
Additional paid-in capital
|
|
|
|
40,435
|
|
|
|
|
40,672
|
|
|
Retained earnings
|
|
|
|
7,060
|
|
|
|
|
2,750
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
323
|
|
|
|
|
(109
|
)
|
|
Treasury stock
|
|
|
|
(11,204
|
)
|
|
|
|
(11,937
|
)
|
|
Total shareholders’ equity
|
|
|
|
36,614
|
|
|
|
|
31,376
|
|
|
Total liabilities and shareholders’ equity
|
|
|
$
|
75,333
|
|
|
|
$
|
67,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF OPERATIONS – (UNAUDITED)
|
|
(in thousands, except per share information)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
Nine months ended
|
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
2015
|
|
2014
|
|
|
2015
|
|
2014
|
|
Net sales
|
|
|
$
|
43,860
|
|
|
$
|
55,635
|
|
|
|
$
|
134,956
|
|
|
$
|
144,900
|
|
|
Cost of sales
|
|
|
|
8,253
|
|
|
|
10,304
|
|
|
|
|
25,076
|
|
|
|
29,440
|
|
|
Gross profit
|
|
|
|
35,607
|
|
|
|
45,331
|
|
|
|
|
109,880
|
|
|
|
115,460
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Commissions and incentives
|
|
|
|
17,867
|
|
|
|
20,977
|
|
|
|
|
54,296
|
|
|
|
57,727
|
|
|
Selling and administrative
|
|
|
|
9,001
|
|
|
|
9,567
|
|
|
|
|
26,412
|
|
|
|
26,389
|
|
|
Depreciation and amortization
|
|
|
|
433
|
|
|
|
441
|
|
|
|
|
1,324
|
|
|
|
1,248
|
|
|
Other operating costs
|
|
|
|
6,072
|
|
|
|
6,149
|
|
|
|
|
18,493
|
|
|
|
19,920
|
|
|
Total operating expenses
|
|
|
|
33,373
|
|
|
|
37,134
|
|
|
|
|
100,525
|
|
|
|
105,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
|
2,234
|
|
|
|
8,197
|
|
|
|
|
9,355
|
|
|
|
10,176
|
|
|
Interest income
|
|
|
|
93
|
|
|
|
25
|
|
|
|
|
154
|
|
|
|
61
|
|
|
Other expense, net
|
|
|
|
(2,418
|
)
|
|
|
(1,167
|
)
|
|
|
|
(3,802
|
)
|
|
|
(1,311
|
)
|
|
Income (loss) before income taxes
|
|
|
|
(91
|
)
|
|
|
7,055
|
|
|
|
|
5,707
|
|
|
|
8,926
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Provision) benefit for income taxes
|
|
|
|
159
|
|
|
|
(1,947
|
)
|
|
|
|
(1,397
|
)
|
|
|
(4,282
|
)
|
|
Net income
|
|
|
$
|
68
|
|
|
$
|
5,108
|
|
|
|
$
|
4,310
|
|
|
$
|
4,644
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.03
|
|
|
$
|
1.92
|
|
|
|
$
|
1.61
|
|
|
$
|
1.75
|
|
|
Diluted
|
|
|
$
|
0.03
|
|
|
$
|
1.89
|
|
|
|
$
|
1.58
|
|
|
$
|
1.71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
2,681
|
|
|
|
2,667
|
|
|
|
|
2,679
|
|
|
|
2,661
|
|
|
Diluted
|
|
|
|
2,721
|
|
|
|
2,701
|
|
|
|
|
2,727
|
|
|
|
2,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures
To supplement our financial results presented in accordance with
generally accepted accounting principles in the United States (“GAAP”),
we disclose operating results that have been adjusted to exclude the
impact of changes due to the translation of foreign currencies into U.S.
dollars, including changes in: Net Sales, Gross Profit, and Income from
Operations. We refer to these adjusted financial measures as constant
dollar items, which are non-GAAP financial measures. We believe these
measures provide investors an additional perspective on trends. To
exclude the impact of changes due to the translation of foreign
currencies into U.S. dollars, we calculate current year results and
prior year results at a constant exchange rate, which is the prior
year’s rate. Currency impact is determined as the difference between
actual growth rates and constant currency growth rates.
|
|
|
|
|
|
|
|
|
|
|
Three month period ended
|
|
September 30, 2015
|
|
|
September 30, 2014
|
|
|
Change
|
|
|
|
GAAP Measure: Total $
|
|
|
Non-GAAP Measure: Constant $
|
|
|
GAAP Measure: Total $
|
|
|
Dollar
|
|
|
Percent
|
|
Net Sales
|
|
$
|
43.9
|
|
|
$
|
48.2
|
|
|
$
|
55.6
|
|
|
$
|
(7.4
|
)
|
|
|
(13.3
|
)%
|
|
Product
|
|
|
35.3
|
|
|
|
38.7
|
|
|
|
45.9
|
|
|
|
(7.2
|
)
|
|
|
(15.7
|
)%
|
|
Pack
|
|
|
7.1
|
|
|
|
8.0
|
|
|
|
7.8
|
|
|
|
0.2
|
|
|
|
2.6
|
%
|
|
Other
|
|
|
1.5
|
|
|
|
1.5
|
|
|
|
1.9
|
|
|
|
(0.4
|
)
|
|
|
(21.1
|
)%
|
|
Gross Profit
|
|
|
35.6
|
|
|
|
39.1
|
|
|
|
45.3
|
|
|
|
(6.2
|
)
|
|
|
(13.7
|
)%
|
|
Income from Operations
|
|
|
2.2
|
|
|
|
2.8
|
|
|
|
8.2
|
|
|
|
(5.4
|
)
|
|
|
(65.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine month period ended
|
|
September 30, 2015
|
|
|
September 30, 2014
|
|
|
Change
|
|
|
|
GAAP Measure: Total $
|
|
|
Non-GAAP Measure: Constant $
|
|
|
GAAP Measure: Total $
|
|
|
Dollar
|
|
|
Percent
|
|
Net Sales
|
|
$
|
135.0
|
|
|
$
|
144.2
|
|
|
$
|
144.9
|
|
|
$
|
(0.7
|
)
|
|
|
(0.5
|
)%
|
|
Product
|
|
|
105.8
|
|
|
|
112.9
|
|
|
|
117.7
|
|
|
|
(4.8
|
)
|
|
|
(4.1
|
)%
|
|
Pack
|
|
|
24.9
|
|
|
|
26.9
|
|
|
|
21.7
|
|
|
|
5.2
|
|
|
|
24.0
|
%
|
|
Other
|
|
|
4.3
|
|
|
|
4.4
|
|
|
|
5.5
|
|
|
|
(1.1
|
)
|
|
|
(20.0
|
)%
|
|
Gross Profit
|
|
|
109.9
|
|
|
|
117.2
|
|
|
|
115.5
|
|
|
|
1.7
|
|
|
|
1.5
|
%
|
|
Income from Operations
|
|
|
9.4
|
|
|
|
10.5
|
|
|
|
10.2
|
|
|
|
0.3
|
|
|
|
2.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The approximate number of new and continuing positions held by
independent associates and members who purchased our packs or products
during the twelve months ended September 30 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2015
|
|
|
2014
|
|
New
|
|
|
|
|
97,000
|
|
|
43.9
|
%
|
|
|
113,000
|
|
|
48.3
|
%
|
|
Continuing
|
|
|
|
|
124,000
|
|
|
56.1
|
%
|
|
|
121,000
|
|
|
51.7
|
%
|
|
Total
|
|
|
|
|
221,000
|
|
|
100.0
|
%
|
|
|
234,000
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales associates around the globe including North America
(United States, Canada, and Mexico), Asia/Pacific (Australia, New
Zealand, Japan, Taiwan, Singapore, the Republic of Korea, and Hong
Kong), and EMEA (Austria, Denmark, Germany, Norway, Sweden, the
Netherlands, the United Kingdom, Estonia, Finland, the Republic of
Ireland, Czech Republic, South Africa, and the Republic of Namibia). For
more information, visit Mannatech.com.
Please Note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “anticipate,” “believe,” “will,” “intend” or
other similar words or the negative of such terminology. Similarly,
descriptions of Mannatech’s objectives, strategies, plans, goals or
targets contained herein are also considered forward-looking statements.
Mannatech believes this release should be read in conjunction with all
of its filings with the United States Securities and Exchange Commission
and cautions its readers that these forward-looking statements are
subject to certain events, risks, uncertainties, and other factors. Some
of these factors include, among others, Mannatech’s inability to attract
and retain associates and members, increases in competition, litigation,
regulatory changes, and its planned growth into new international
markets. Although Mannatech believes that the expectations, statements,
and assumptions reflected in these forward-looking statements are
reasonable, it cautions readers to always consider all of the risk
factors and any other cautionary statements carefully in evaluating each
forward-looking statement in this release, as well as those set forth in
its latest Annual Report on Form 10-K, and other filings filed with the
United States Securities and Exchange Commission, including its current
reports on Form 8-K. All of the forward-looking statements contained
herein speak only as of the date of this release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151110005463/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Donna Giordano, 972-471-6512
Manager,
Executive Office Administration
ir@mannatech.com
www.mannatech.com